Following the company’s fourth quarter results, RBC analyst Maxim Matushansky has retained his “Outperform” rating on Calian Group (Calian Group Stock Quote, Chart, News, Analysts, Financials TSX:CGY), though he has lowered his expectation slightly.
On November 27, CGY reported its Q4, 2023 results. The company posted Adjusted EBITDA of $20-million on revenue of $176-million, a topline that was up ten per cent over the same period a year prior.
“We finished the year with a record quarter as revenues, gross margin and adjusted EBITDA reached new historical highs,” CEO Kevin Ford said. “In FY23 we generated double-digit revenue growth with all four segments contributing. Our adjusted EBITDA remained flat. With two recent acquisitions and adjustments in our operating costs, we are poised to see continued increase in our profitability. Given the ongoing robust demand for our products and services, the contribution from recent acquisitions and the benefits from our restructuring plan, we are confident in our ability to post another record year. At the midpoint of our guidance range this translates into revenue and adjusted EBITDA growth of 15 per cent and 32 per cent, respectively, over FY23.”
As reported in the Globe and Mail, Matushansky has lowered his price target on Calian Group from $70.00 to $65.00. The stock closed November 28 at $52.08.
Top-line growth is still an issue, but Roth MKM analyst Richard K. Baldry thinks there are green shoots appearing for… [Read More]
Following the report of record November numbers, Eight Capital analyst Kiran Sritharan has raised his price target on WonderFi Technologies… [Read More]
Who will benefit from a more than favorable environment for AI infrastructure demand? Roth MKM analyst Suji Desilva has one… [Read More]
Shopify's (Shopify Stock Quote, Chart, News, Analysts, Financials NYSE:SHOP) Black Friday data tradition continued this week and National Bank Financial… [Read More]
Another acquisition is in the books and Haywood analyst Gianluca Tucci remains bullish on HEALWELL AI (HEALWELL AI Stock Quote,… [Read More]
Following a recent development, Ventum Capital Markets analyst Andrew Semple remains bullish on High Tide (High Tide Stock Quote, Chart,… [Read More]